Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000848

Type of data
NGS (WGS)
Access criteria
Controlled-access (Type I)
Total data volume
129 MB
File formats
  • VCF
  • TSV
Research
hum0127
Date published
2024-07-10
Date modified
2024-07-10

Analysis method

WGS

Materials and participants
cancer (ICD10: C169, C170, C18 (180, 182, 184, 186, 187), C20, C220, C349, C433, C437, C445, C541, C56, C787, C793, C795, C08.1): 177 cases in which no changes in driver genes were detected by whole exon sequencing and whole gene expression analysis
tumor tissue: 177 samples
paired peripheral blood cells: 177 samples
  • Health status
    Affected
  • Subject count
    177 (Individual)
Disease
cancer (C169, C170, C18, C180, C182, C184, C186, C187, C20, C220, C349, C433, C437, C445, C541, C56, C787, C793, C795, C081)
Sample description
DNAs extracted from peripheral blood cells (non-tumor tissues) and surgically dissected tumor tissues
  • Tissue
    Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WGS
Target
N/A
Reagent kit
TruSeq DNA PCR-Free Library Prep Kit
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp
Reference genome
GRCh37
Mapping
DRAGEN DNA Pipeline
Mapping quality
DRAGEN DNA Pipeline
Analysis method
Illumina DRAGEN Secondary Analysis
Coverage (depth)
Tumor samples: 130.3x
Tumor samples: 115.7–150.7x (Range)
Blood samples: 36.2x
Blood samples: 28.8–45.9x (Range)
Processed data type
CNV
Variant calls